| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncolytic Virotherapy | 45 | 2024 | 521 | 5.900 |
Why?
|
| Simplexvirus | 57 | 2022 | 805 | 5.660 |
Why?
|
| Herpesvirus 1, Human | 32 | 2021 | 744 | 2.870 |
Why?
|
| Oncolytic Viruses | 26 | 2023 | 345 | 2.600 |
Why?
|
| Glioblastoma | 44 | 2024 | 3523 | 2.570 |
Why?
|
| Brain Neoplasms | 68 | 2024 | 9182 | 1.990 |
Why?
|
| Meningioma | 33 | 2023 | 1222 | 1.490 |
Why?
|
| Genetic Vectors | 41 | 2018 | 3417 | 1.470 |
Why?
|
| Virus Replication | 35 | 2018 | 2459 | 1.420 |
Why?
|
| Neoplastic Stem Cells | 16 | 2019 | 1357 | 1.380 |
Why?
|
| Interleukin-12 | 9 | 2018 | 578 | 1.350 |
Why?
|
| Antineoplastic Agents, Alkylating | 5 | 2020 | 618 | 1.270 |
Why?
|
| Neuroma, Acoustic | 21 | 2012 | 458 | 1.150 |
Why?
|
| Mice, Nude | 45 | 2014 | 3635 | 1.060 |
Why?
|
| Meningeal Neoplasms | 22 | 2023 | 1251 | 1.030 |
Why?
|
| Glioma | 32 | 2019 | 3523 | 0.960 |
Why?
|
| Neurilemmoma | 13 | 2014 | 524 | 0.900 |
Why?
|
| Angiostatins | 2 | 2013 | 64 | 0.830 |
Why?
|
| Dacarbazine | 4 | 2011 | 560 | 0.790 |
Why?
|
| Neurofibromatosis 1 | 22 | 2004 | 561 | 0.740 |
Why?
|
| Tumor Cells, Cultured | 37 | 2019 | 6135 | 0.720 |
Why?
|
| Angiogenesis Inhibitors | 7 | 2014 | 2062 | 0.720 |
Why?
|
| Herpes Simplex | 9 | 2024 | 470 | 0.660 |
Why?
|
| Neoplasm Transplantation | 29 | 2017 | 2017 | 0.650 |
Why?
|
| Vero Cells | 14 | 2018 | 486 | 0.560 |
Why?
|
| Mice | 96 | 2024 | 82045 | 0.560 |
Why?
|
| Prostatic Neoplasms | 12 | 2012 | 11206 | 0.560 |
Why?
|
| Nervous System Neoplasms | 9 | 1992 | 91 | 0.560 |
Why?
|
| Ganciclovir | 8 | 2001 | 256 | 0.540 |
Why?
|
| Xenograft Model Antitumor Assays | 16 | 2020 | 3619 | 0.520 |
Why?
|
| Neovascularization, Pathologic | 8 | 2018 | 2643 | 0.500 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2018 | 665 | 0.490 |
Why?
|
| Combined Modality Therapy | 23 | 2018 | 8559 | 0.470 |
Why?
|
| Animals | 122 | 2024 | 169418 | 0.460 |
Why?
|
| Neurosurgical Procedures | 6 | 2017 | 2097 | 0.450 |
Why?
|
| Cell Line, Tumor | 26 | 2020 | 17149 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 22 | 13 | 2000 | 348 | 0.430 |
Why?
|
| Neurofibroma | 6 | 2001 | 95 | 0.400 |
Why?
|
| Occipital Lobe | 1 | 2014 | 376 | 0.390 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2012 | 624 | 0.380 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2011 | 70 | 0.370 |
Why?
|
| Vinblastine | 1 | 2012 | 488 | 0.370 |
Why?
|
| Neoplasms, Experimental | 9 | 2008 | 1232 | 0.360 |
Why?
|
| Nerve Sheath Neoplasms | 5 | 2014 | 170 | 0.360 |
Why?
|
| Dilazep | 1 | 2010 | 4 | 0.360 |
Why?
|
| Organ Culture Techniques | 2 | 2010 | 796 | 0.360 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2010 | 17 | 0.350 |
Why?
|
| Neuroblastoma | 7 | 2005 | 1265 | 0.350 |
Why?
|
| Dipyridamole | 1 | 2010 | 143 | 0.340 |
Why?
|
| Etoposide | 1 | 2011 | 640 | 0.340 |
Why?
|
| Mice, Inbred BALB C | 21 | 2012 | 6241 | 0.330 |
Why?
|
| Retroviridae | 6 | 1997 | 850 | 0.320 |
Why?
|
| Sesquiterpenes | 3 | 1995 | 177 | 0.320 |
Why?
|
| Genetic Engineering | 6 | 2009 | 936 | 0.310 |
Why?
|
| Microsurgery | 1 | 2014 | 803 | 0.300 |
Why?
|
| Thymidine Kinase | 9 | 2001 | 286 | 0.300 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2010 | 458 | 0.290 |
Why?
|
| Psychosurgery | 3 | 2005 | 86 | 0.290 |
Why?
|
| Immunotherapy | 9 | 2021 | 4728 | 0.290 |
Why?
|
| Transfection | 14 | 2006 | 5767 | 0.270 |
Why?
|
| Neurofibromatosis 2 | 6 | 2006 | 384 | 0.270 |
Why?
|
| TCF Transcription Factors | 1 | 2006 | 138 | 0.260 |
Why?
|
| Ribonucleotide Reductases | 3 | 2010 | 75 | 0.260 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2007 | 133 | 0.260 |
Why?
|
| Thrombospondins | 1 | 2007 | 195 | 0.260 |
Why?
|
| Viral Vaccines | 3 | 1999 | 596 | 0.260 |
Why?
|
| DNA Viruses | 1 | 2005 | 33 | 0.260 |
Why?
|
| Brain Diseases | 5 | 2019 | 1553 | 0.260 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 83 | 0.250 |
Why?
|
| Disease Models, Animal | 20 | 2020 | 18388 | 0.250 |
Why?
|
| Taxoids | 1 | 2009 | 669 | 0.250 |
Why?
|
| Cancer Vaccines | 5 | 2001 | 1044 | 0.250 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 259 | 0.240 |
Why?
|
| Hydroxamic Acids | 1 | 2008 | 482 | 0.240 |
Why?
|
| Humans | 173 | 2024 | 768451 | 0.240 |
Why?
|
| DNA Damage | 3 | 2011 | 2461 | 0.240 |
Why?
|
| Oligodendroglioma | 2 | 2016 | 278 | 0.240 |
Why?
|
| Cytopathogenic Effect, Viral | 8 | 2012 | 152 | 0.240 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2006 | 895 | 0.240 |
Why?
|
| RNA Viruses | 1 | 2005 | 110 | 0.240 |
Why?
|
| Radiotherapy, Adjuvant | 6 | 2020 | 1794 | 0.230 |
Why?
|
| Hematoporphyrins | 4 | 1988 | 23 | 0.230 |
Why?
|
| Cytotoxicity, Immunologic | 5 | 2018 | 1355 | 0.230 |
Why?
|
| Chromosome Deletion | 5 | 1997 | 1390 | 0.230 |
Why?
|
| Antineoplastic Agents | 11 | 2011 | 13708 | 0.230 |
Why?
|
| Facial Paralysis | 2 | 2006 | 346 | 0.220 |
Why?
|
| Virus Shedding | 2 | 2001 | 110 | 0.220 |
Why?
|
| DNA Repair | 4 | 2017 | 2051 | 0.220 |
Why?
|
| Viral Proteins | 6 | 2018 | 1803 | 0.220 |
Why?
|
| Gene Transfer Techniques | 5 | 2010 | 1209 | 0.220 |
Why?
|
| Adenocarcinoma | 5 | 2007 | 6400 | 0.210 |
Why?
|
| Subrenal Capsule Assay | 5 | 1994 | 27 | 0.200 |
Why?
|
| Injections, Intralesional | 5 | 2014 | 281 | 0.200 |
Why?
|
| Cell Division | 9 | 2001 | 4479 | 0.200 |
Why?
|
| Gene Deletion | 6 | 2018 | 2674 | 0.200 |
Why?
|
| Astrocytoma | 6 | 2016 | 780 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 5709 | 0.200 |
Why?
|
| Biological Therapy | 2 | 2001 | 140 | 0.200 |
Why?
|
| Immunohistochemistry | 11 | 2018 | 11138 | 0.190 |
Why?
|
| Tumor Microenvironment | 6 | 2024 | 3939 | 0.190 |
Why?
|
| beta Catenin | 1 | 2006 | 1048 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 19 | 2018 | 22365 | 0.180 |
Why?
|
| Transgenes | 6 | 2021 | 1015 | 0.180 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2020 | 138 | 0.180 |
Why?
|
| Neurofibromatoses | 2 | 2002 | 300 | 0.180 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2006 | 783 | 0.170 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 1995 | 679 | 0.170 |
Why?
|
| Ethmoid Sinus | 1 | 2000 | 58 | 0.170 |
Why?
|
| Osteomalacia | 1 | 2000 | 60 | 0.170 |
Why?
|
| Hemangiopericytoma | 1 | 2000 | 71 | 0.170 |
Why?
|
| Defective Viruses | 3 | 2000 | 89 | 0.170 |
Why?
|
| Mutation | 19 | 2016 | 30243 | 0.160 |
Why?
|
| Postoperative Complications | 5 | 2012 | 15880 | 0.160 |
Why?
|
| DNA, Neoplasm | 12 | 1994 | 1749 | 0.160 |
Why?
|
| Hypophosphatemia | 1 | 2000 | 93 | 0.160 |
Why?
|
| Gyrus Cinguli | 4 | 1995 | 1136 | 0.160 |
Why?
|
| Cerebellopontine Angle | 4 | 2006 | 53 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 4586 | 0.160 |
Why?
|
| Cell Survival | 9 | 2017 | 5801 | 0.160 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2023 | 928 | 0.160 |
Why?
|
| Hematoporphyrin Photoradiation | 3 | 1986 | 17 | 0.150 |
Why?
|
| DNA Modification Methylases | 2 | 2011 | 210 | 0.150 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2000 | 155 | 0.150 |
Why?
|
| Stereotaxic Techniques | 4 | 2005 | 556 | 0.150 |
Why?
|
| Female | 84 | 2020 | 396943 | 0.150 |
Why?
|
| Fractures, Spontaneous | 1 | 2000 | 232 | 0.150 |
Why?
|
| Pericytes | 1 | 2020 | 299 | 0.150 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2000 | 243 | 0.140 |
Why?
|
| Moloney murine leukemia virus | 3 | 1993 | 110 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2022 | 9425 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2015 | 3520 | 0.140 |
Why?
|
| Macrophages | 5 | 2018 | 5797 | 0.140 |
Why?
|
| Transplantation, Heterologous | 9 | 2011 | 2393 | 0.140 |
Why?
|
| DNA Repair Enzymes | 2 | 2011 | 347 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2020 | 772 | 0.140 |
Why?
|
| Cell Growth Processes | 2 | 2007 | 383 | 0.130 |
Why?
|
| DNA, Viral | 3 | 2017 | 2206 | 0.130 |
Why?
|
| Single-Cell Analysis | 3 | 2016 | 2531 | 0.130 |
Why?
|
| Rad51 Recombinase | 1 | 2017 | 191 | 0.130 |
Why?
|
| Watchful Waiting | 1 | 2020 | 496 | 0.130 |
Why?
|
| Obsessive-Compulsive Disorder | 4 | 1995 | 1509 | 0.130 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2006 | 2331 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1999 | 1797 | 0.130 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 664 | 0.130 |
Why?
|
| Male | 68 | 2020 | 364781 | 0.130 |
Why?
|
| Critical Pathways | 1 | 2019 | 476 | 0.120 |
Why?
|
| Cytokines | 4 | 2004 | 7449 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2022 | 12813 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 9623 | 0.120 |
Why?
|
| Skin Neoplasms | 9 | 2001 | 5891 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2000 | 539 | 0.110 |
Why?
|
| Rats, Inbred F344 | 6 | 2011 | 826 | 0.110 |
Why?
|
| Phthalazines | 1 | 2017 | 396 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5152 | 0.110 |
Why?
|
| Mice, SCID | 5 | 2019 | 2633 | 0.110 |
Why?
|
| Estradiol | 4 | 1986 | 1949 | 0.110 |
Why?
|
| Schwann Cells | 6 | 2004 | 196 | 0.110 |
Why?
|
| Lac Operon | 2 | 1992 | 237 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 998 | 0.110 |
Why?
|
| Hearing Disorders | 2 | 1992 | 126 | 0.110 |
Why?
|
| Photochemotherapy | 4 | 1991 | 832 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 1992 | 419 | 0.110 |
Why?
|
| beta-Galactosidase | 6 | 1995 | 575 | 0.110 |
Why?
|
| Cell Hypoxia | 2 | 2015 | 661 | 0.110 |
Why?
|
| Rats | 19 | 2011 | 23839 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 5 | 2011 | 6091 | 0.110 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2016 | 954 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2013 | 36840 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2015 | 8635 | 0.110 |
Why?
|
| Melanins | 3 | 1999 | 290 | 0.100 |
Why?
|
| HeLa Cells | 3 | 2008 | 3090 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 5342 | 0.100 |
Why?
|
| Biological Products | 2 | 2021 | 937 | 0.100 |
Why?
|
| Cranial Fossa, Middle | 1 | 2012 | 29 | 0.100 |
Why?
|
| Occipital Bone | 1 | 2012 | 55 | 0.100 |
Why?
|
| Indazoles | 1 | 2014 | 306 | 0.100 |
Why?
|
| Ear Neoplasms | 1 | 2013 | 118 | 0.100 |
Why?
|
| Radiosurgery | 3 | 2005 | 1354 | 0.100 |
Why?
|
| Brain | 8 | 2010 | 27438 | 0.100 |
Why?
|
| Antiviral Agents | 3 | 2001 | 3063 | 0.100 |
Why?
|
| Genes, Neurofibromatosis 1 | 3 | 2004 | 74 | 0.100 |
Why?
|
| Acid Phosphatase | 2 | 2010 | 139 | 0.100 |
Why?
|
| Acyclovir | 1 | 1993 | 267 | 0.100 |
Why?
|
| Tubulin Modulators | 1 | 2012 | 107 | 0.100 |
Why?
|
| Dexamethasone | 1 | 1999 | 1965 | 0.100 |
Why?
|
| Ear, Inner | 2 | 2013 | 426 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2024 | 4642 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 2018 | 9263 | 0.100 |
Why?
|
| Transcription, Genetic | 5 | 2006 | 7599 | 0.100 |
Why?
|
| Vaccination | 2 | 2021 | 3434 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2016 | 2039 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 621 | 0.090 |
Why?
|
| Immunization | 2 | 2010 | 1220 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1999 | 1536 | 0.090 |
Why?
|
| Mice, Inbred A | 4 | 2011 | 245 | 0.090 |
Why?
|
| Onium Compounds | 1 | 1991 | 27 | 0.090 |
Why?
|
| Apoptosis | 8 | 2017 | 9526 | 0.090 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 3463 | 0.090 |
Why?
|
| Spinal Nerves | 1 | 1991 | 92 | 0.090 |
Why?
|
| Tourette Syndrome | 1 | 1994 | 400 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 4362 | 0.090 |
Why?
|
| Signal Transduction | 7 | 2018 | 23638 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1143 | 0.090 |
Why?
|
| Vestibule, Labyrinth | 1 | 2012 | 235 | 0.090 |
Why?
|
| Sciatic Nerve | 2 | 2001 | 628 | 0.090 |
Why?
|
| Clinical Trials as Topic | 2 | 2005 | 8051 | 0.090 |
Why?
|
| Cobalt Radioisotopes | 2 | 1988 | 75 | 0.090 |
Why?
|
| Injections | 2 | 2011 | 840 | 0.080 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2010 | 136 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1992 | 694 | 0.080 |
Why?
|
| Organophosphorus Compounds | 1 | 1991 | 207 | 0.080 |
Why?
|
| Ki-67 Antigen | 3 | 2017 | 631 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2017 | 5042 | 0.080 |
Why?
|
| Cyclohexanes | 3 | 1995 | 152 | 0.080 |
Why?
|
| Recombinases | 2 | 2006 | 70 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 2003 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2018 | 4419 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 3637 | 0.080 |
Why?
|
| Immediate-Early Proteins | 2 | 2001 | 444 | 0.080 |
Why?
|
| Flow Cytometry | 3 | 2013 | 5904 | 0.080 |
Why?
|
| Base Sequence | 6 | 2006 | 12428 | 0.080 |
Why?
|
| Encephalitis | 1 | 1993 | 441 | 0.080 |
Why?
|
| Treatment Outcome | 13 | 2020 | 65409 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2013 | 724 | 0.080 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1989 | 43 | 0.080 |
Why?
|
| Methylation | 1 | 2011 | 1077 | 0.080 |
Why?
|
| Y Chromosome | 1 | 1990 | 205 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 2819 | 0.080 |
Why?
|
| Neuroma | 1 | 1991 | 138 | 0.080 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2012 | 497 | 0.080 |
Why?
|
| Aotidae | 2 | 2000 | 58 | 0.080 |
Why?
|
| Cell Line | 13 | 2012 | 15609 | 0.080 |
Why?
|
| Neural Stem Cells | 2 | 2016 | 892 | 0.080 |
Why?
|
| Neural Cell Adhesion Molecules | 2 | 2000 | 122 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2011 | 1650 | 0.080 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2001 | 254 | 0.080 |
Why?
|
| Imidazoles | 1 | 2014 | 1174 | 0.080 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 202 | 0.080 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1988 | 21 | 0.080 |
Why?
|
| Cytotoxicity Tests, Immunologic | 4 | 2001 | 317 | 0.080 |
Why?
|
| Tumor Stem Cell Assay | 3 | 2017 | 116 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2018 | 2929 | 0.070 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2008 | 190 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3816 | 0.070 |
Why?
|
| Camptothecin | 1 | 2011 | 594 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 2 | 1992 | 1064 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2001 | 3735 | 0.070 |
Why?
|
| Peroxidase | 1 | 2011 | 610 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2000 | 10784 | 0.070 |
Why?
|
| Lasers | 1 | 1992 | 952 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2017 | 2942 | 0.070 |
Why?
|
| Random Allocation | 3 | 2014 | 2399 | 0.070 |
Why?
|
| Membrane Proteins | 3 | 2020 | 7895 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2009 | 370 | 0.070 |
Why?
|
| Cell Proliferation | 8 | 2019 | 10494 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2834 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1608 | 0.070 |
Why?
|
| Edema | 1 | 2011 | 766 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 1990 | 962 | 0.070 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1991 | 595 | 0.070 |
Why?
|
| Safety | 2 | 2005 | 1159 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 6978 | 0.070 |
Why?
|
| Tumor Burden | 1 | 2012 | 1909 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 4 | 2014 | 4417 | 0.070 |
Why?
|
| Platelet Factor 4 | 1 | 2006 | 132 | 0.070 |
Why?
|
| Piperazines | 1 | 2017 | 2546 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 3 | 1987 | 590 | 0.070 |
Why?
|
| Comet Assay | 1 | 2006 | 75 | 0.070 |
Why?
|
| Cyclin D1 | 1 | 2008 | 454 | 0.060 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2006 | 196 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2011 | 2465 | 0.060 |
Why?
|
| Caco-2 Cells | 1 | 2006 | 365 | 0.060 |
Why?
|
| Hearing Loss | 2 | 2009 | 786 | 0.060 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 182 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2007 | 9558 | 0.060 |
Why?
|
| Chromosome Disorders | 2 | 1988 | 499 | 0.060 |
Why?
|
| HCT116 Cells | 1 | 2006 | 406 | 0.060 |
Why?
|
| Arachnoid | 2 | 1985 | 50 | 0.060 |
Why?
|
| Mental Disorders | 2 | 2005 | 6879 | 0.060 |
Why?
|
| Antibodies, Viral | 4 | 2000 | 3212 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 5 | 2006 | 5803 | 0.060 |
Why?
|
| Protein Phosphatase 1 | 1 | 2006 | 135 | 0.060 |
Why?
|
| Postoperative Period | 3 | 2020 | 1833 | 0.060 |
Why?
|
| Genes, MHC Class I | 1 | 2006 | 236 | 0.060 |
Why?
|
| Ethics Committees, Clinical | 1 | 2005 | 56 | 0.060 |
Why?
|
| Antigens, Differentiation | 2 | 2006 | 920 | 0.060 |
Why?
|
| Neurosurgery | 1 | 1992 | 690 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 3437 | 0.060 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 1669 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2010 | 1183 | 0.060 |
Why?
|
| Mice, Inbred Strains | 3 | 2007 | 1770 | 0.060 |
Why?
|
| Middle Aged | 33 | 2020 | 223418 | 0.060 |
Why?
|
| Gene Expression | 8 | 2009 | 7605 | 0.060 |
Why?
|
| Cranial Nerve Neoplasms | 2 | 1985 | 134 | 0.060 |
Why?
|
| Carrier Proteins | 4 | 2002 | 4948 | 0.060 |
Why?
|
| Aotus trivirgatus | 2 | 2001 | 36 | 0.060 |
Why?
|
| Guanine | 1 | 2006 | 279 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3734 | 0.060 |
Why?
|
| Injections, Subcutaneous | 3 | 2001 | 681 | 0.060 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2012 | 125 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2000 | 413 | 0.060 |
Why?
|
| Adenoviridae | 2 | 2020 | 1098 | 0.060 |
Why?
|
| Melanosis | 1 | 1985 | 93 | 0.060 |
Why?
|
| Tamoxifen | 2 | 1986 | 968 | 0.060 |
Why?
|
| Growth Substances | 1 | 1986 | 761 | 0.060 |
Why?
|
| Stem Cell Factor | 1 | 2004 | 195 | 0.060 |
Why?
|
| Interleukin-18 | 1 | 2005 | 251 | 0.060 |
Why?
|
| Endothelium, Vascular | 4 | 2008 | 4425 | 0.060 |
Why?
|
| Progesterone | 2 | 1985 | 750 | 0.060 |
Why?
|
| Neurofibromin 1 | 2 | 2002 | 190 | 0.060 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2009 | 507 | 0.060 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2005 | 225 | 0.060 |
Why?
|
| Mitogens | 2 | 2001 | 229 | 0.050 |
Why?
|
| Hematoporphyrin Derivative | 3 | 1988 | 10 | 0.050 |
Why?
|
| Laser Therapy | 1 | 1990 | 1107 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2006 | 716 | 0.050 |
Why?
|
| Neoplasms | 6 | 2021 | 22386 | 0.050 |
Why?
|
| ras Proteins | 1 | 2008 | 1058 | 0.050 |
Why?
|
| Progestins | 1 | 1985 | 302 | 0.050 |
Why?
|
| Prognosis | 8 | 2019 | 30028 | 0.050 |
Why?
|
| Adult | 35 | 2019 | 223542 | 0.050 |
Why?
|
| Cranial Nerves | 1 | 2003 | 98 | 0.050 |
Why?
|
| Heparin | 1 | 1990 | 1636 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 4 | 1991 | 767 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2024 | 191 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2005 | 716 | 0.050 |
Why?
|
| Audiometry, Evoked Response | 4 | 1992 | 45 | 0.050 |
Why?
|
| Sarcoma, Myeloid | 1 | 2003 | 52 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 1990 | 1836 | 0.050 |
Why?
|
| Karyotyping | 3 | 1991 | 1173 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2004 | 2847 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2019 | 2656 | 0.050 |
Why?
|
| Plasmids | 2 | 2006 | 2269 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 1988 | 1781 | 0.050 |
Why?
|
| Disease Progression | 5 | 2019 | 13655 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 1990 | 1325 | 0.050 |
Why?
|
| Blotting, Southern | 3 | 1991 | 777 | 0.050 |
Why?
|
| Cytosol | 1 | 1985 | 889 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1249 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 9507 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2018 | 10273 | 0.050 |
Why?
|
| Facial Neuralgia | 1 | 1981 | 10 | 0.050 |
Why?
|
| Temperature | 3 | 2000 | 2237 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 699 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2006 | 1765 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2014 | 10125 | 0.050 |
Why?
|
| Primates | 2 | 2001 | 523 | 0.050 |
Why?
|
| Blood-Brain Barrier | 2 | 2005 | 1034 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 13589 | 0.050 |
Why?
|
| Bone Marrow Purging | 1 | 2001 | 108 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 2008 | 3169 | 0.050 |
Why?
|
| Alleles | 5 | 2002 | 6890 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 1992 | 1668 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1170 | 0.050 |
Why?
|
| Organ Size | 1 | 2006 | 2268 | 0.050 |
Why?
|
| Melanocytes | 1 | 1984 | 512 | 0.050 |
Why?
|
| Protein Kinase C | 2 | 1996 | 1207 | 0.050 |
Why?
|
| Retrospective Studies | 11 | 2020 | 81834 | 0.050 |
Why?
|
| Aged | 23 | 2020 | 171520 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2001 | 252 | 0.040 |
Why?
|
| Haplorhini | 1 | 2001 | 524 | 0.040 |
Why?
|
| DNA Primers | 2 | 2005 | 2826 | 0.040 |
Why?
|
| Neuroendocrine Tumors | 1 | 2007 | 649 | 0.040 |
Why?
|
| Genetic Markers | 8 | 1997 | 2604 | 0.040 |
Why?
|
| Skin | 4 | 2004 | 4520 | 0.040 |
Why?
|
| Cells, Cultured | 10 | 2014 | 19041 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1999 | 58 | 0.040 |
Why?
|
| Fibroblasts | 1 | 1990 | 4180 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 183 | 0.040 |
Why?
|
| Adenoma | 1 | 1990 | 2163 | 0.040 |
Why?
|
| Cysts | 2 | 1985 | 685 | 0.040 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2012 | 195 | 0.040 |
Why?
|
| Microscopy, Electron | 3 | 1990 | 2565 | 0.040 |
Why?
|
| Astrocytes | 3 | 2013 | 1354 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 17647 | 0.040 |
Why?
|
| Follow-Up Studies | 9 | 2015 | 39430 | 0.040 |
Why?
|
| World Health Organization | 2 | 2015 | 1328 | 0.040 |
Why?
|
| Drug Resistance | 3 | 1994 | 1599 | 0.040 |
Why?
|
| Time Factors | 10 | 2006 | 40271 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 1 | 2005 | 636 | 0.040 |
Why?
|
| Tears | 1 | 2000 | 252 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 871 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2014 | 6610 | 0.040 |
Why?
|
| Neurites | 2 | 2000 | 391 | 0.040 |
Why?
|
| Brain Injuries | 1 | 1990 | 2060 | 0.040 |
Why?
|
| Breast Neoplasms | 3 | 2005 | 21156 | 0.040 |
Why?
|
| Sarcoma | 1 | 1990 | 1806 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11843 | 0.040 |
Why?
|
| Estrogens | 1 | 1985 | 1531 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 6527 | 0.040 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2009 | 1671 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2001 | 4572 | 0.040 |
Why?
|
| Androgens | 1 | 2005 | 1285 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1999 | 190 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 2884 | 0.040 |
Why?
|
| Somatostatin | 1 | 2000 | 448 | 0.040 |
Why?
|
| Glutamate Decarboxylase | 1 | 1998 | 239 | 0.040 |
Why?
|
| Genes, Neurofibromatosis 2 | 2 | 2000 | 122 | 0.040 |
Why?
|
| Receptors, Estrogen | 2 | 1986 | 2243 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2022 | 776 | 0.040 |
Why?
|
| Viruses | 1 | 2001 | 373 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2008 | 2757 | 0.040 |
Why?
|
| Mitotic Index | 1 | 2017 | 164 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2000 | 561 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2024 | 1894 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2020 | 489 | 0.040 |
Why?
|
| Quinazolinones | 1 | 2019 | 222 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2005 | 2772 | 0.030 |
Why?
|
| Diphtheria Toxin | 1 | 1997 | 253 | 0.030 |
Why?
|
| Antibodies, Neoplasm | 2 | 1976 | 283 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2018 | 446 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 4931 | 0.030 |
Why?
|
| Thionucleotides | 1 | 1996 | 107 | 0.030 |
Why?
|
| Transferrin | 1 | 1997 | 285 | 0.030 |
Why?
|
| Chromosome Mapping | 7 | 1997 | 4622 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1997 | 286 | 0.030 |
Why?
|
| Sphingosine | 1 | 2018 | 308 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 1985 | 2889 | 0.030 |
Why?
|
| Lymphopenia | 1 | 2018 | 290 | 0.030 |
Why?
|
| Survival Rate | 4 | 2010 | 12875 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2018 | 338 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2019 | 20762 | 0.030 |
Why?
|
| Saliva | 1 | 2000 | 854 | 0.030 |
Why?
|
| Herpesviridae | 1 | 1996 | 104 | 0.030 |
Why?
|
| Cell Differentiation | 4 | 2016 | 11674 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2001 | 1251 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2000 | 1998 | 0.030 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2005 | 1398 | 0.030 |
Why?
|
| Leukocytes | 5 | 1990 | 2030 | 0.030 |
Why?
|
| Receptors, Progesterone | 3 | 1986 | 1145 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2020 | 1335 | 0.030 |
Why?
|
| DNA, Antisense | 1 | 1994 | 44 | 0.030 |
Why?
|
| Biopsy | 3 | 2019 | 6816 | 0.030 |
Why?
|
| DNA Probes | 3 | 1991 | 542 | 0.030 |
Why?
|
| Vagina | 1 | 2000 | 845 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 427 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2019 | 1615 | 0.030 |
Why?
|
| Cerebellum | 2 | 2000 | 1515 | 0.030 |
Why?
|
| Radiotherapy Dosage | 3 | 2005 | 2925 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 1362 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 1529 | 0.030 |
Why?
|
| Escherichia coli | 3 | 1992 | 4220 | 0.030 |
Why?
|
| Hearing | 2 | 2009 | 502 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2017 | 556 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 1995 | 315 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2000 | 1282 | 0.030 |
Why?
|
| Digoxin | 1 | 2015 | 246 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2005 | 3122 | 0.030 |
Why?
|
| Melanoma | 2 | 2024 | 5740 | 0.030 |
Why?
|
| DNA | 5 | 2009 | 7213 | 0.030 |
Why?
|
| Endocytosis | 1 | 2018 | 960 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 1997 | 1526 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1991 | 851 | 0.030 |
Why?
|
| Skull Base Neoplasms | 1 | 2017 | 281 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1996 | 462 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2015 | 286 | 0.030 |
Why?
|
| Isoenzymes | 2 | 1996 | 1685 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2014 | 190 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 2415 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 2238 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 1885 | 0.030 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1973 | 45 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2000 | 1427 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2006 | 4175 | 0.030 |
Why?
|
| Optic Nerve | 1 | 1977 | 572 | 0.030 |
Why?
|
| Facial Nerve | 3 | 1987 | 277 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 369 | 0.030 |
Why?
|
| Body Weight | 2 | 1995 | 4630 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 182 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2003 | 2994 | 0.030 |
Why?
|
| Cisplatin | 1 | 1999 | 1661 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 85 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1738 | 0.030 |
Why?
|
| Prostate | 1 | 2001 | 1781 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2001 | 1973 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1995 | 475 | 0.030 |
Why?
|
| Plasmacytoma | 1 | 1993 | 171 | 0.030 |
Why?
|
| Mutagenesis | 2 | 2000 | 1230 | 0.030 |
Why?
|
| Virus Latency | 1 | 1995 | 360 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 1 | 2012 | 249 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1561 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 1994 | 478 | 0.020 |
Why?
|
| Spleen | 1 | 2018 | 2298 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1998 | 1140 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2008 | 3594 | 0.020 |
Why?
|
| Gene Order | 1 | 2012 | 169 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1992 | 277 | 0.020 |
Why?
|
| Phosphonoacetic Acid | 1 | 1991 | 54 | 0.020 |
Why?
|
| Heterozygote | 3 | 1999 | 2792 | 0.020 |
Why?
|
| Virulence | 1 | 1995 | 1303 | 0.020 |
Why?
|
| Foscarnet | 1 | 1991 | 36 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 1995 | 1525 | 0.020 |
Why?
|
| Dequalinium | 1 | 1991 | 7 | 0.020 |
Why?
|
| Point Mutation | 1 | 2016 | 1596 | 0.020 |
Why?
|
| Neurons | 3 | 2000 | 9504 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 1995 | 1502 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 10865 | 0.020 |
Why?
|
| Temporal Bone | 3 | 1991 | 683 | 0.020 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 1992 | 255 | 0.020 |
Why?
|
| Genome, Viral | 1 | 1995 | 673 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2013 | 348 | 0.020 |
Why?
|
| Pedigree | 4 | 1992 | 4545 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2012 | 179 | 0.020 |
Why?
|
| Neuroglia | 1 | 2016 | 961 | 0.020 |
Why?
|
| Autophagy | 2 | 2012 | 1349 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6537 | 0.020 |
Why?
|
| Speech Discrimination Tests | 2 | 1992 | 35 | 0.020 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1990 | 152 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 1994 | 679 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 706 | 0.020 |
Why?
|
| Recurrence | 2 | 2017 | 8510 | 0.020 |
Why?
|
| Risk Factors | 3 | 2019 | 74915 | 0.020 |
Why?
|
| Vidarabine | 1 | 1991 | 337 | 0.020 |
Why?
|
| DNA Replication | 1 | 2017 | 1428 | 0.020 |
Why?
|
| Consumer Product Safety | 2 | 2001 | 122 | 0.020 |
Why?
|
| Adolescent | 11 | 2015 | 89168 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 3713 | 0.020 |
Why?
|
| Oncogenes | 2 | 1987 | 1235 | 0.020 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 59680 | 0.020 |
Why?
|
| Hybridomas | 1 | 1990 | 444 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 1993 | 1158 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 2087 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 1995 | 6035 | 0.020 |
Why?
|
| Lymphocytes | 2 | 1990 | 2611 | 0.020 |
Why?
|
| Phylogeny | 1 | 2016 | 2846 | 0.020 |
Why?
|
| Child | 8 | 2004 | 80863 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 1999 | 11930 | 0.020 |
Why?
|
| Introns | 1 | 1991 | 970 | 0.020 |
Why?
|
| Bystander Effect | 1 | 2009 | 90 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 1973 | 992 | 0.020 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1991 | 263 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1992 | 649 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 1990 | 624 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2009 | 323 | 0.020 |
Why?
|
| Antineoplastic Protocols | 1 | 2008 | 48 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2533 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1999 | 4083 | 0.020 |
Why?
|
| Young Adult | 4 | 2019 | 60045 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 2046 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2012 | 8332 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1992 | 1091 | 0.020 |
Why?
|
| Indoles | 2 | 1994 | 1834 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 548 | 0.020 |
Why?
|
| Epigenomics | 1 | 2013 | 956 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1706 | 0.020 |
Why?
|
| Medulloblastoma | 1 | 1992 | 682 | 0.020 |
Why?
|
| X Chromosome | 1 | 1990 | 819 | 0.020 |
Why?
|
| Glia Maturation Factor | 1 | 1986 | 13 | 0.020 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1986 | 45 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9376 | 0.020 |
Why?
|
| Genome, Human | 2 | 2009 | 4453 | 0.020 |
Why?
|
| Capgras Syndrome | 1 | 1986 | 10 | 0.020 |
Why?
|
| Bone Density | 1 | 2000 | 3561 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1994 | 1348 | 0.020 |
Why?
|
| Methylnitrosourea | 1 | 1986 | 30 | 0.020 |
Why?
|
| Adenine | 1 | 2012 | 993 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 617 | 0.020 |
Why?
|
| Selection Bias | 1 | 2008 | 360 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 903 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 1992 | 952 | 0.020 |
Why?
|
| Craniotomy | 1 | 1990 | 748 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1660 | 0.020 |
Why?
|
| Culture Techniques | 2 | 1977 | 530 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 1305 | 0.020 |
Why?
|
| Tritium | 1 | 1986 | 707 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2000 | 13026 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1990 | 555 | 0.020 |
Why?
|
| Cell Movement | 2 | 2009 | 5223 | 0.020 |
Why?
|
| Receptors, Estradiol | 1 | 1985 | 18 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 1992 | 1238 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 1503 | 0.020 |
Why?
|
| Albumins | 2 | 1999 | 578 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2006 | 455 | 0.020 |
Why?
|
| Caloric Tests | 1 | 1985 | 10 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 1489 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1986 | 292 | 0.020 |
Why?
|
| Hospitals | 1 | 2019 | 3906 | 0.020 |
Why?
|
| Osmosis | 1 | 2005 | 103 | 0.020 |
Why?
|
| Myelography | 2 | 1982 | 72 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2007 | 732 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 2005 | 181 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6856 | 0.020 |
Why?
|
| Glomus Jugulare Tumor | 1 | 1985 | 35 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1991 | 716 | 0.010 |
Why?
|
| Albinism | 1 | 1984 | 25 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1999 | 2915 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2017 | 24311 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2006 | 978 | 0.010 |
Why?
|
| Kinetics | 2 | 2011 | 6348 | 0.010 |
Why?
|
| Cell Line, Transformed | 2 | 1997 | 868 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2015 | 4029 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 1985 | 156 | 0.010 |
Why?
|
| RNA Interference | 1 | 2013 | 2832 | 0.010 |
Why?
|
| Monophenol Monooxygenase | 1 | 1984 | 72 | 0.010 |
Why?
|
| Drug Implants | 1 | 2005 | 231 | 0.010 |
Why?
|
| Audiometry | 1 | 1985 | 253 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2006 | 856 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1992 | 1924 | 0.010 |
Why?
|
| DNA Mutational Analysis | 2 | 2004 | 4120 | 0.010 |
Why?
|
| Genes | 1 | 1987 | 1824 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2298 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1984 | 699 | 0.010 |
Why?
|
| Reoperation | 1 | 1994 | 4342 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1983 | 261 | 0.010 |
Why?
|
| Phenotype | 3 | 2011 | 16712 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2015 | 41797 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1986 | 1543 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2001 | 5709 | 0.010 |
Why?
|
| Lipoma | 1 | 1985 | 296 | 0.010 |
Why?
|
| Metrizamide | 1 | 1982 | 17 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1984 | 946 | 0.010 |
Why?
|
| Genotype | 2 | 2011 | 13047 | 0.010 |
Why?
|
| Promegestone | 1 | 1981 | 9 | 0.010 |
Why?
|
| Nevus, Pigmented | 1 | 1984 | 225 | 0.010 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1982 | 54 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 1985 | 396 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2007 | 1531 | 0.010 |
Why?
|
| Brain Edema | 1 | 1986 | 608 | 0.010 |
Why?
|
| Aneurysm | 1 | 1985 | 338 | 0.010 |
Why?
|
| Dogs | 1 | 1986 | 3847 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1999 | 1368 | 0.010 |
Why?
|
| Chromatin | 1 | 2013 | 2969 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4877 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3794 | 0.010 |
Why?
|
| Immunotherapy, Active | 1 | 2001 | 58 | 0.010 |
Why?
|
| Eye Neoplasms | 1 | 1983 | 307 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1991 | 2964 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1990 | 1905 | 0.010 |
Why?
|
| Lod Score | 2 | 1992 | 600 | 0.010 |
Why?
|
| Age of Onset | 2 | 2000 | 3342 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2005 | 943 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3826 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1990 | 6320 | 0.010 |
Why?
|
| Lipomatosis | 1 | 1981 | 112 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 2089 | 0.010 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2000 | 94 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1983 | 625 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2005 | 1246 | 0.010 |
Why?
|
| Cochlear Nerve | 1 | 1982 | 202 | 0.010 |
Why?
|
| Retinoblastoma | 1 | 1983 | 321 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2010 | 22293 | 0.010 |
Why?
|
| Hemangioma | 1 | 1985 | 727 | 0.010 |
Why?
|
| Cushing Syndrome | 1 | 1981 | 241 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2000 | 265 | 0.010 |
Why?
|
| RNA | 1 | 2009 | 2727 | 0.010 |
Why?
|
| K562 Cells | 1 | 2001 | 645 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 3550 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1991 | 3611 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 1981 | 234 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7956 | 0.010 |
Why?
|
| Solubility | 1 | 2001 | 1086 | 0.010 |
Why?
|
| Neurofibromin 2 | 1 | 2000 | 272 | 0.010 |
Why?
|
| Insect Proteins | 1 | 2000 | 254 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2001 | 285 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1984 | 657 | 0.010 |
Why?
|
| Genetic Linkage | 3 | 1990 | 2342 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1986 | 1041 | 0.010 |
Why?
|
| Microglia | 1 | 2007 | 1376 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1998 | 203 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 2640 | 0.010 |
Why?
|
| Protons | 1 | 2003 | 1113 | 0.010 |
Why?
|
| Hamartoma | 1 | 2000 | 236 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3245 | 0.010 |
Why?
|
| Risk Management | 1 | 2001 | 558 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 1435 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1999 | 595 | 0.010 |
Why?
|
| Glycosylation | 1 | 2000 | 1100 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1990 | 4505 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1990 | 3861 | 0.010 |
Why?
|
| Parents | 1 | 1991 | 3596 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 1629 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 1755 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1984 | 1539 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2000 | 842 | 0.010 |
Why?
|
| Neurology | 1 | 2005 | 786 | 0.010 |
Why?
|
| Mosaicism | 1 | 2000 | 481 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1987 | 3442 | 0.010 |
Why?
|
| Proteomics | 1 | 2010 | 3901 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2004 | 1884 | 0.010 |
Why?
|
| United States | 1 | 2024 | 73121 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 1982 | 982 | 0.010 |
Why?
|
| Glutamates | 1 | 1976 | 385 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 1706 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2000 | 1136 | 0.010 |
Why?
|
| Goals | 1 | 2000 | 715 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1985 | 3783 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 1994 | 113 | 0.010 |
Why?
|
| G2 Phase | 1 | 1994 | 136 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12096 | 0.010 |
Why?
|
| Polymorphism, Genetic | 2 | 1997 | 4249 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 12174 | 0.010 |
Why?
|
| Cataract | 1 | 2000 | 837 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 2000 | 711 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 1995 | 299 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2005 | 15460 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 2000 | 715 | 0.010 |
Why?
|
| Models, Animal | 1 | 2000 | 2126 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3790 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1993 | 227 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3612 | 0.010 |
Why?
|
| Speech Reception Threshold Test | 1 | 1992 | 16 | 0.010 |
Why?
|
| Immunoconjugates | 1 | 2001 | 968 | 0.010 |
Why?
|
| Ependyma | 1 | 1973 | 57 | 0.010 |
Why?
|
| Cerebral Aqueduct | 1 | 1973 | 40 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2005 | 2347 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 18478 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2004 | 3586 | 0.010 |
Why?
|
| Lung | 2 | 2005 | 10090 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 1992 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2000 | 1725 | 0.010 |
Why?
|
| Psychotic Disorders | 1 | 1986 | 3278 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 3484 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1992 | 781 | 0.010 |
Why?
|
| Probability | 1 | 1995 | 2483 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 1995 | 885 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 7575 | 0.010 |
Why?
|
| Cricetinae | 1 | 1973 | 2423 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2001 | 2544 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2001 | 3408 | 0.000 |
Why?
|
| Child, Preschool | 2 | 2004 | 42623 | 0.000 |
Why?
|
| Adjuvants, Immunologic | 1 | 1993 | 998 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1998 | 8201 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2003 | 3623 | 0.000 |
Why?
|
| Intraoperative Period | 1 | 1987 | 513 | 0.000 |
Why?
|
| Cerebral Arterial Diseases | 1 | 1986 | 82 | 0.000 |
Why?
|
| Hydrocephalus | 1 | 1973 | 770 | 0.000 |
Why?
|
| Pain | 1 | 1981 | 5096 | 0.000 |
Why?
|
| Psychotropic Drugs | 1 | 1991 | 888 | 0.000 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1987 | 533 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1992 | 6353 | 0.000 |
Why?
|
| Psychotherapy | 1 | 1991 | 1656 | 0.000 |
Why?
|
| Cauda Equina | 1 | 1981 | 45 | 0.000 |
Why?
|
| Comorbidity | 1 | 1995 | 10601 | 0.000 |
Why?
|
| Epidural Space | 1 | 1981 | 123 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1987 | 1797 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1987 | 1795 | 0.000 |
Why?
|
| Nerve Compression Syndromes | 1 | 1981 | 160 | 0.000 |
Why?
|
| Angiography | 1 | 1985 | 1598 | 0.000 |
Why?
|
| Forecasting | 1 | 1987 | 2950 | 0.000 |
Why?
|
| Intracranial Aneurysm | 1 | 1986 | 1318 | 0.000 |
Why?
|
| Radiography | 1 | 1986 | 6995 | 0.000 |
Why?
|
| Infant | 1 | 1977 | 36497 | 0.000 |
Why?
|
| Quality of Life | 1 | 1995 | 13497 | 0.000 |
Why?
|
| Sodium | 1 | 1976 | 1595 | 0.000 |
Why?
|
| Acute Disease | 1 | 1982 | 7246 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1995 | 54914 | 0.000 |
Why?
|